Lupin launches Clomipramine Hydrochloride Capsules

05 Feb 2019 Evaluate

Lupin has launched Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier.

The company’s Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg is the generic equivalent of SP ECGX LLC's Anafranil Capsules, 25 mg, 50 mg, and 75 mg. It is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg had annual sales of $96.2 million in the US (IQVIA MAT December 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2154.90 -23.30 (-1.07%)
20-Jan-2026 10:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.00
Dr. Reddys Lab 1164.30
Cipla 1378.30
Zydus Lifesciences 881.00
Lupin 2154.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×